Mobile Health (mHealth) App for Safe Opioid Use

Last updated: September 21, 2021
Sponsor: Rutgers, The State University of New Jersey
Overall Status: Active - Enrolling

Phase

N/A

Condition

Drug Use

Treatment

N/A

Clinical Study ID

NCT04462250
Pro2020001699
  • Ages 18-65
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

A key driver of the current opioid overdose epidemic is the misuse of legitimately prescribed opioid medications. Patient education through use of mobile technology may help to increase knowledge of appropriate use of opioid medications; however, knowledge does not always translate into behavior modification. Therefore, there is a need for more research into patient-facing technology that can increase both knowledge and behaviors consistent with appropriate opioid use. These needs have been amplified by the severe acute respiratory syndrome coronavirus-2 (COVID-19) pandemic, which has exposed healthcare disparities, heightened the risk for mental and behavioral health disorders, and dramatically increased reliance on telehealth technologies. It is critically important that telehealth solutions be accessible and user-friendly for all consumers, particularly members of underserved communities with limited digital health literacy. This feasibility study will develop a mobile health app to improve appropriate use of opioid medications among patients with a prescription to treat non-cancer pain. The study will use focus groups with consumers and providers to determine the content and features to be included in the app and will test the feasibility of implementing a contingency management approach (i.e., rewards system) with the app using a randomized control trial. The key outcome of interest is confirmation of the design and operating specifications of the app, including the use of contingency management. Secondary outcomes of interest are the overall rating of the app and an increase in knowledge among users regarding the safe use, storage, and disposal of opioid medications.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Has current prescription for opioid medication
  • Any ethnic group
  • Served through the following programs of partnering organization: primary medicalcare, transgender medical care, HIV and sexually transmitted infection (STI) screeningand counseling, LGBTQ services, pre-exposure prophylaxis and post exposure prophylaxisservices, health education, clinical research, case management, psychosocial services,nutrition counseling, treatment adherence
  • Owns an Android-base smartphone

Exclusion

Exclusion Criteria:

  • Unable to provide informed consent
  • Pregnant women
  • Currently being treated for/history of mental health or substance use disorder

Study Design

Total Participants: 15
Study Start date:
August 24, 2020
Estimated Completion Date:
May 31, 2022

Connect with a study center

  • North Jersey Community Research Initiative

    Newark, New Jersey 07103
    United States

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.